Nampt-IN-3 (Compound 35) simultaneously inhibit nicotinamide phosphoribosyltransferase ( NAMPT ) and HDAC with IC 50 s of 31 nM and 55 nM, respectively. Nampt-IN-3 effectively induces cell apoptosis and autophagy and ultimately leads to cell death.
Nampt-IN-3 (Compound 35) simultaneously inhibit nicotinamide phosphoribosyltransferase ( NAMPT ) and HDAC with IC 50 s of 31 nM and 55 nM, respectively. Nampt-IN-3 effectively induces cell apoptosis and autophagy and ultimately leads to cell death.
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC 50 s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectivelyIn VitroNampt-IN-5 (compound 27) (0-10 nM:
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in
Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC 50 of 3.1 nM.In VitroTo assess its selectivity, specificity, and effects on cellular NAD + levels, LSN3154567 is characterized in